参考文献
1.DelValle J. 卓-艾综合征。胃肠肽类激素基础与临床(陈元芳,Tadataka Yamada主编)。第一版。北京:北京医科大学中国协合医科大学联合出版社,1997,678-700
2.Rehfeld JF. 胃泌素和胆囊收缩素家族。胃肠肽类激素基础与临床。(陈元方,Tadataka Yamada主编)。第一版。北京:北京医科大学中国协和医科大学联合出版社,1997,129-168
3.江石湖,吴裕忻。Zollinger-Ellison综合征及胃泌素瘤。江绍基临床胃肠病学(萧树东主编)。第一版。上海:上海科学技术出版社,2001,696-704
4.Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Current Treatment Options in Gastroenterology, 2003, 6:163-170
5.Smith M, Watson SA. gastrin and colorectal cancer. Aliment Pharmacol Ther, 2000, 14:1231-1247
6.Chen D, Zhao CM, Dockray GJ, et al. Glycine-extended gastrin synergizes with gastrin 17 to simulate acid secretion in gastrin-deficient mice. Gastroenterology, 2000, 119: 756-765
7.Hansen CP, Stadil F, Rehfeld JF. Metabolism and influence of glycine-extended gastrin on gastric acid secretion in man. Digestion, 1996, 57: 22-29
8.Higashide S, Gomez G, Greeley GH, et al. Glycine-extended gastrin potentiates gastrin-stimulated gastric acid secretion in rats. Am J Physiol, 1996, 270: G220-G224
9.Renga M, Brandi G, Paganelli GM, et al. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut, 1997,41:330-332
10 Orbuch M, Venzon DJ, Lubensky IA, et al. Polonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome. Dig Dis Sci, 1996, 41: 604-613
11.Thorburn CM, Friedman GD, Dickinson CJ, et al. Gastrin and colorectal cancer: a prospective study. Gastroenterology, 1998,115:275-280
12.Annibale B, Azzoni C, Corleto VD, et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol, 2001, 13(12):1449-1456.
13.Peghini PL, Annibale B, Azzoni C, et al. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology, 2002, 123(1):68-85
14.Robinson. Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia. Aliment Pharmacol Ther, 1999, 13 Suppl 5:5-10.
15.Pashankar DS, Israel DM. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr, 2002, 35(5):658-662.
16.Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore), 2000, 79(6):379-411
17.Gibril F, Venzon DJ, Ojeaburu JV, et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab, 2001, 86(11):5282-5293
18.Okuzawa A, Kobayashi S, Sakamoto K, et al. Metastatic gastrinoma to the liver 20 years after primary resection. J Gastroenterol, 2000, 35(9):717-720
19.Philippe J, Michel M. Normal serum gastrin concentration in gastrinoma. Lancet, 1995, 346(25):1421-1422
20.Lew EA, Pisegna JR, Starr JA, et al. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology, 2000, 118(4):696-704
21.Metz DC, Soffer E, Forsmark CE, et al. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. Am J Gastroenterol, 2003, 98(2):301-307
22.Shojamanesh H, Gibril F, Louie A, et al. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer, 2002, 94(2):331-343 更多胃泌素瘤相关知识请关注专题:浅谈胃泌素瘤的诊疗